Chondromyxoid fibroma
| Chondromyxoid fibroma | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Pain, Swelling |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Unknown |
| Risks | |
| Diagnosis | X-ray, MRI, Biopsy |
| Differential diagnosis | Chondroblastoma, Osteosarcoma, Giant cell tumor of bone |
| Prevention | |
| Treatment | Surgical excision |
| Medication | |
| Prognosis | Generally good with treatment |
| Frequency | Rare |
| Deaths | |
Chondromyxoid fibroma (CMF) is a rare type of bone tumor that typically occurs in the long bones of the legs, but can also be found in the bones of the hands, feet, spine, ribs, and skull. It is the least common of the cartilaginous tumors, accounting for less than 1% of all bone tumors.
Etiology[edit]
The exact cause of chondromyxoid fibroma is unknown. However, it is believed to arise from the cartilage cells that line the ends of the bones. Some researchers suggest that it may be related to an abnormal response to injury or inflammation, but this theory has not been definitively proven.
Clinical Presentation[edit]
Patients with chondromyxoid fibroma typically present with pain and swelling in the affected bone. The pain is often worse at night and may be relieved by rest. In some cases, the tumor may cause a visible deformity or limit the range of motion in the affected joint.
Diagnosis[edit]
The diagnosis of chondromyxoid fibroma is typically made based on a combination of clinical symptoms, radiographic findings, and histopathologic examination of a biopsy specimen. On radiographs, the tumor appears as a well-defined, lytic lesion with a thin rim of reactive bone. The histopathologic features include a mixture of cartilage, myxoid tissue, and fibrous tissue, hence the name "chondromyxoid fibroma".
Treatment[edit]
The standard treatment for chondromyxoid fibroma is surgical removal of the tumor. This can often be accomplished through a procedure known as curettage, in which the tumor is scraped out of the bone. In some cases, bone grafting may be necessary to fill the defect left by the tumor. The prognosis following treatment is generally good, with a low rate of recurrence.
See Also[edit]
This bone tumor related article is a stub. You can help WikiMD by expanding it.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian